Medpace Holdings Inc. (01P)
XDUS
Real-time Data
06:00 AM
Day's Range
502.2052 wk Range
327.40Overview - 01P - Medpace Holdings Inc.
Key Statistics
Valuation
P/E (Trailing)
‪32.96‬
PEG Ratio
‪0.90‬
Price / Book
‪33.48‬
Profitability
Gross Margin
‪28.50%‬
Profit Margin
‪30.06%‬
Operating Margin
‪21.14%‬
Return on Assets
‪22.83%‬
Return on Equity
‪98.26%‬
Ownership
Shares Outstanding
27.91M
Price stats
50-Day Avg
‪474.24‬
200-Day Avg
‪440.00‬
Peers - 01P - Medpace Holdings Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- 01PXDUSMedpace Holdings Inc.+24.64%52-week change33.31P/E (Trailing)‪30.06%‬Profit Margin
- NL0XDUSGrail, Inc.+57.14%52-week change-5.92P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.56%52-week change-93.46P/E (Trailing)‪50.72%‬Profit Margin
- 1K9XDUSCareDx Inc.+74.05%52-week change-101.50P/E (Trailing)‪67.55%‬Profit Margin
- 04XXDUSPersonalis Inc.+66.42%52-week change-13.21P/E (Trailing)‪22.65%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+64.09%52-week change-41.53P/E (Trailing)‪64.46%‬Profit Margin
- NG9XDUSNeoGenomics Inc.+61.51%52-week change-16.39P/E (Trailing)‪43.21%‬Profit Margin
Profile Summary - 01P - Medpace Holdings Inc.
About
Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehensive clinical development support across phases I through IV,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
